Greater Manchester Mental Health NHS Foundation Trust has been shortlisted for two awards at the forthcoming Greater Manchester Health and Care Research Awards 2022.
Motiv8, a weight management programme for people in secure mental health settings is a finalist in the ‘Best Public Engagement’ category, while Miriam Avery, NIHR Clinical Doctoral Research Fellow, has been shortlisted for ‘Exceptional Research Delivery Leadership’.
Almost 200 nominations were received, with submissions coming from across Greater Manchester, East Cheshire and East Lancashire. The awards are organised by NIHR Clinical Research Network Greater Manchester. The winners will be announced in a ceremony at The Etihad Stadium on Thursday 29th September.
Listening to the ‘patient voice’ in the Motiv8 weight management programme
The award for Best Public Engagement will recognise projects which ensure that research is being carried out ‘with’ members of the public. A key part of the Motiv8 programme involves listening to the ‘patient voice’, and a public and patient group of service users with lived experience provides regular advice, guidance and feedback to the research team.
Professor Sophie Parker, Chief Investigator on Motiv8 said:
“Involving people who use mental health services in the development and application of clinical research is crucial. Without this inclusion, we run the risk of our research not being as meaningful or important to those we are hoping to develop services for.
“This is also paramount in the area of mental health research, where service users can often face significant stigma and challenges to having their voices heard.
“We are incredibly proud to be shortlisted for the Best Public Engagement Award and to have worked with an amazing group of dedicated Patient and Public Involvement group members, whose input has been invaluable to the success of this project.
“We really hope this experience can be shared and shows what is achievable when you strive to engage with patients and the public in research.”
Miriam Avery shortlisted for Exceptional Research Delivery Leadership
The Exceptional Research Delivery Leadership award recognises strong leadership in research delivery. Miriam Avery, currently an NIHR Clinical Doctoral Research Fellow, who previously worked as a clinical research nurse on the Biohaven OCD study, a trial investigating the effectiveness of Troriluzole in the treatment of OCD, was nominated by Sarah Leo, Head of Research and Innovation at GMMH.
“Miriam played a key role in the success of our ongoing commercial Biohaven OCD trial, which is testing whether Troriluzole, a drug which targets glutamate in the brain, is effective in reducing symptoms in people with OCD. Miriam was integral to the trial reaching its recruitment targets and this has helped to cement GMMH’s reputation as a leading research organisation.
“At the same time, Miriam has also been accepted as an NIHR Clinical Research Fellow. With her strong track record in mental health research, I have no doubt she will bring the same successes to her doctoral research focused on developing mental health liaison services for young people in England.”
Miriam Avery, NIHR Clinical Doctoral Fellow at GMMH and the University of Manchester, commented:
“I’m delighted to be shortlisted for the exceptional leadership in research delivery award. Currently there are very limited treatment options for people with OCD, yet the symptoms can be extremely debilitating, which is why this trial is so important. However, recruitment into this study was not straightforward, largely due to very strict eligibility criteria. Despite these challenges, we met our recruitment target, and we continue to recruit for more.”